Dr. Anthony Lembo, MD

• Gastroenterology

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Ronald Reagan Ucla Medical Center

  Fellowship Hospital

• Ronald Reagan Ucla Medical Center

  Residency Hospital, 1993

• Ronald Reagan Ucla Medical Center

  Internship Hospital, 1991

• Tufts University

  Medical School, 1990

• Genotypes of Pain and Analgesia in a Randomized Trial of Irritable Bowel Syndrome, 2022-03-23

• Genomic Effects Associated With Response to Placebo Treatment in a Randomized Trial of Irritable Bowel Syndrome, 2022-01-04

• Treatment ofHelicobacter pyloriInfection with Intra-Gastric Violet Light Phototherapy - a Pilot Clinical Trial, 2009-12-18

• Complementary and Alternative Medicine Use by U.S. Adults with Gastrointestinal Conditions: Results from the 2012 National Health Interview Survey, 2014-07-08

• Adequate Relief in a Treatment Trial with IBS Patients: A Prospective Assessment, 2009-03-17

• A TREATMENT TRIAL OF ACUPUNCTURE IN IBS PATIENTS, 2009-05-05

• Polyethylene Glycol 3350 in the Treatment of Chronic Idiopathic Constipation: Post hoc Analysis Using FDA Endpoints, 2022-09-09

• Conscientiousness is modified by genetic variation in catechol-O-methyltransferase to reduce symptom complaints in IBS patients, 2014-11-13

• Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial, 2015-07-29

• Patient-Provider Interactions Affect Symptoms in Gastroesophageal Reflux Disease: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial, 2015-09-30

• Patient and Practitioner Influences on the Placebo Effect in Irritable Bowel Syndrome, 2009-08-06

• Catechol-O-Methyltransferase val158met Polymorphism Predicts Placebo Effect in Irritable Bowel Syndrome, 2012-10-23